6-9 September 2018 | Kaohsiung, Taiwan

20th Asia Pacific League of Associations for Rheumatology Congress

6-9 September 2018 | Kaohsiung, Taiwan

Yoshiya Tanaka, M.D., Ph.D

Professor and Chairman of the First Department of Internal Medicine, School of Medicine / Dean of Graduate School of Medical Science - University of Occupational and Environmental Health, Japan

Yoshiya Tanaka, MD, PhD is Professor and Chairman of the First Department of Internal Medicine, School of Medicine (2000-present) and Dean of the Graduate School of Medical Science (2017-present), at the University of Occupational and Environmental Health, Japan.

He gained his PhD in 1988 from the University of Occupational and Environmental Health, Japan and this was followed by a visiting fellowship in the Experimental Immunology Branch at the National Cancer Institute, National Institutes of Health, USA (1989-92). Prof. Tanaka has authored and/or reviewed 557 publications (IF=2312) in English and his scientific focus lies on pathological analysis and development of novel treatments in systemic autoimmune diseases, rheumatic diseases and endocrine metabolic diseases including osteoporosis.

Between 2013-2015, Prof. Tanaka was president of the Japanese Society of Bone and Mineral Research (JSBMR) and is now a vice-president of Asia Pacific League of Associations for Rheumatology (APLAR). He is also a director board member of the Japanese Society of Internal Medicine, Japanese College of Rheumatology (JCR), Japanese Association of Clinical Immunology, and the Japanese Society of Inflammation and Regeneration.

He is editor-in-chief of Modern Rheumatology Case Reports, and an associate editor of Rheumatology, Cytokine, Arthritis Care and Research, Arthritis Research & Therapy, Inflammation Research, and the International Journal of Rheumatic Diseases. He is also an editorial board member of Annals of Rheumatic Diseases, RMD Open, Modern Rheumatology, and Inflammation Research, and has received awards from the Japanese Society of Inflammation, JSBMR, JCR, and the European League against Rheumatism (EULAR).